Navigation Links
Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
Date:7/22/2008

to help manage the potential risks that come with prolonged hyperglycemia," said Dr. Bergenstal. "The Adjust to Target trial demonstrated that basal-bolus insulin therapy may be an effective option for the many people with type 2 diabetes who are not achieving glycemic targets with their current insulin regimen."

About the Trial

Study participants were 28-71 years old, had type 2 diabetes for greater than or equal to 6 months and mean +/- SD A1C values of 8.1 +/- 0.9% (Simplified Algorithm) and 8.3 +/- 0.9% (Carb Counting Algorithm) at screening. They had taken greater than or equal to 2 insulin injections/day (36 percent on 2 injections, 64 percent on more than 2 injections) +/- metformin (one-third were on metformin), for greater than or equal to 3 months before study entry. Upon entry into the study, 37 percent were using Lantus(R) and at least one injection of a rapid-acting insulin analog, 36 percent were using a pre-mixed insulin and the remainder were on a combination of various other diabetes treatment regimens.

About Diabetes

Diabetes is a chronic, widespread condition in which the body does not produce or properly use insulin -- the hormone needed to transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwide are living with the disease and this number is expected to rise to a staggering 350 million within 20 years. It is estimated more than 20 million Americans have diabetes, including an estimated 6.2 million who remain undiagnosed.

At the same time, more than 40 percent of those diagnosed are not achieving the blood sugar control target of A1C <7 percent recommended by the American Diabetes Association (ADA). The A1C test measures average blood glucose levels over a two- to three-month period.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the live
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
4. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
5. New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
6. Newly Approved HIV Drug Shows Great Promise
7. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
8. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
9. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 Bayer HealthCare (Bayer) has entered ... (NASDAQ: ISIS ) on ISIS-FXI Rx, an ... of thrombosis. Under the agreement Bayer will further develop ... unmet medical need. As part of the clinical development ... ISIS-FXI Rx in an appropriate patient community. ...
(Date:5/4/2015)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) has ... (Bayer) to develop and commercialize ISIS-FXI Rx for ... agreement, Isis is eligible to receive up to $155 ... up-front payment and a $55 million payment upon advancement ... patients with compromised kidney function. Isis is also eligible ...
(Date:5/4/2015)... , May 4, 2015  FireflySci Inc., the newest member of the cuvette manufacturing ... they have turned the cuvette industry on its head by offering scientists amazing support for their ... Photo - http://photos.prnewswire.com/prnh/20150501/213244 ... ... ...
Breaking Medicine Technology:Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 2Bayer Licenses Investigational ISIS FXI(Rx) from Isis Pharmaceuticals to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3
... PharmaTech (Cayman) Inc. (NYSE: WX ), a ... with operations in China and the United States, today ... second quarter of 2011 after the New York Stock ... be Thursday morning, August 11, 2011 Shanghai time). The ...
... RAPIDS, Mich., July 19, 2011 ... rehabilitation and software services that benefit patients, healthcare ... to its multi-state group of outpatient clinics.  Agility ... the Company,s Michigan-based outpatient clinic presence to 23 ...
Cached Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 2Agility Health Expands National Outpatient Clinic Group with New Michigan Facility 2
(Date:5/4/2015)... 2015 Leonardo J. Lozada, M.D., Saint ... executive, and William C. Daniel, M.D., Saint Luke’s Health ... invitations from the Secretary of the Air Force to ... the Air War College, Maxwell Air Force Base, Alabama. ... to senior U.S. and international officers and their civilian ...
(Date:5/4/2015)... New York (PRWEB) May 04, 2015 ... as $2.4 billion to settle thousands of Actos lawsuits ... diabetes medication increases the risk that a patient will ... on April 28th, if 95% of those eligible for ... resolve nearly 9,000 bladder cancer cases currently pending in ...
(Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ... center on Wednesday, April 22. , Johnson & Wales becomes ... by the re-alignment of Interstate-195. JWU’s new academic building, which ... streets in Providence, is scheduled to be completed in July ... the university purchased in 2012. , “It has long been ...
(Date:5/4/2015)... The American Telemedicine Association (ATA) today released an update ... in coverage and reimbursement, and physician practice standards and ... Reports last September, many state regulating bodies responded by ... delivery in their state,” said Jonathan Linkous, CEO of ... nation, ATA reevaluated the indicators for each state and ...
(Date:5/4/2015)... May 04, 2015 METTLER TOLEDO ... Importance of Data Integrity in a GXP Regulated ... guest presenter. This webinar will be presented on ... , Data integrity is a critical component of ... regulatory agencies. However, in recent years an increasing ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Health System Leadership Selected to Attend National Security Forum 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 2Health News:Actos Lawsuit Settlement: Takeda Pharmaceutical Co. to Pay As Much As $2.4 Billion to Resolve Claims Alleging Actos Causes Bladder Cancer 3Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 2Health News:American Telemedicine Association Delivers New State Report Cards on Telemedicine 3Health News:METTLER TOLEDO Announces Live Webinar on the Importance of Data Integrity in a GXP Regulated Laboratory 2
... spot teens prone to violence , , SATURDAY, Aug. 18 ... down fellow students in the hallways or grounds of ... This is an extreme form of shyness affecting mostly ... that seen at Columbine, Colo., or, most recently, Virginia ...
... found , FRIDAY, Aug. 17 (HealthDay News) -- Dirty ... pointing to heart risk in young adults, a Taiwanese ... oxidative stress, and blood coagulation, according to the study, ... Journal of Respiratory and Critical Care Medicine . , ...
... is 10th leading killer in United States, experts say ... they appear clinically similar, patients with potentially deadly sepsis ... U.S. researchers who conducted the first large-scale natural history ... result of the body,s inflammatory response to infection -- ...
... study finds , , FRIDAY, Aug. 17 (HealthDay News) -- Depression ... returning from duty in Iraq or Afghanistan, placing a tremendous ... , Researchers studied the home life of 168 soldiers diagnosed ... half -- 42 percent -- of these veterans said they ...
... quickly, raising chance of morphine overdose for baby , , ... use medicines containing codeine and metabolize the drug quickly ... morphine overdose, U.S. health officials said Friday. , ... by a report of the death of a 13-day-old ...
... trouble in September, experts say , , FRIDAY, Aug. ... that establishing regular sleep habits should be included on ... their sleep schedules about two weeks prior to the ... National Sleep Foundation. Children need adequate sleep in order ...
Cached Medicine News:Health News:Does Pathological Shyness Make for School Shooters? 2Health News:Does Pathological Shyness Make for School Shooters? 3Health News:Does Pathological Shyness Make for School Shooters? 4Health News:Urban Smog Tough on Young Adults' Hearts 2Health News:Scientists Probe Sepsis' Deadly Secrets 2Health News:Depression Taking Toll on Returning U.S. Vets 2Health News:Depression Taking Toll on Returning U.S. Vets 3Health News:Depression Taking Toll on Returning U.S. Vets 4Health News:FDA Warns of Codeine Risk for Some Nursing Mothers 2Health News:FDA Warns of Codeine Risk for Some Nursing Mothers 3Health News:Time to Set Kids' Back-to-School Sleep Clocks 2
Inquire...
... • V-shaped bottom allows easy ... or 5 per bag ,• Corner ... Pipettor Solution Basin designed for 4, 8, ... V-shaped bottom permits withdrawal of practically all ...
... Calibration Software monitors and documents the accuracy ... entire operating life. This new program was ... from gravimetric or photometric pipette tests. It ... types from various manufacturers and other liquid ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile...
Medicine Products: